Results 141 to 150 of about 1,815 (196)

Microsurgical reconstruction after foot eumycetoma excision: Description of two cases. [PDF]

JPRAS Open
Mariani M, Lhuaire M, Canoui E, Knipper P, Garrido I, Biau D, Lantieri LA, Pozzo V.   +7 more
europepmc   +1 more source

Global sociodemographic, clinical, and epidemiological profiling of patients with mycetoma: A systematic review. [PDF]

PLoS Negl Trop Dis
Salah ME, Salah ME, Fearon Scales ML, Habib K, Alhamwi F, Abdelwahab S, Ahmed Y, Khalid MM, Smith DJ, Fahal A.   +9 more
europepmc   +1 more source

Genetic variability, antigenicity and antifungal susceptibility of Madurella mycetomatis [PDF]

, 2007
Laureijssen - van de Sande, Wendy
core  

Sandalwood Oils of Different Origins Are Active In Vitro against <i>Madurella mycetomatis</i>, the Major Fungal Pathogen Responsible for Eumycetoma. [PDF]

Molecules
Abd Algaffar SO, Seegers S, Satyal P, Setzer WN, Schmidt TJ, Khalid SA.   +5 more
europepmc   +1 more source

Developing and implementing molecular diagnostic tools for Mycetoma in Sudan [PDF]

Siddig, Emmanuel
core   +2 more sources

Antiparasitic and Antifungal Activities of Cetyl-Maritima, a New <i>N</i>-Cetyl-Modified Maritima Derivative. [PDF]

Antibiotics (Basel)
Al Nasr IS, Ma J, Khan TA, Koko WS, Ben Abdelmalek I, Schobert R, van de Sande W, Biersack B.   +7 more
europepmc   +1 more source

Antifungal activity of the antimicrobial peptide RP557 against priority fungal pathogens. [PDF]

Microbiology (Reading)
Poester VR, Xavier MO, Hidalgo JED, Dos Santos MC, Trápaga MR, Al-Hatmi AMS, Jaynes J, Stevens DA.   +7 more
europepmc   +1 more source

Special Issue "Antifungal Drug Discovery: Progresses, Challenges, Opportunities". [PDF]

Int J Mol Sci
Biersack B.
europepmc   +1 more source

Diagnosing and monitoring drug response in madurella mycetomatis, the most common causative agent of eumycetoma [PDF]

Nyuykonge, Bertrand
core   +2 more sources